You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Johnson and Johnson
Harvard Business School
AstraZeneca
Baxter

Last Updated: September 19, 2020

DrugPatentWatch Database Preview

Litigation Details for Merck & Cie v. Watson Laboratories Inc. (D. Del. 2013)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Merck & Cie v. Watson Laboratories Inc.
The small molecule drugs covered by the patent cited in this case are   Start Trial and   Start Trial .

Details for Merck & Cie v. Watson Laboratories Inc. (D. Del. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-07-23 1 relating thereto. 18. The patent-in-suit is U.S. Patent No. 6,441,168 (the “’168 Patent”) (attached hereto as…exclusive license. CLAIM FOR PATENT INFRINGEMENT OF UNITED STATES PATENT NO. 6,441.168 21. Plaintiffs incorporate…filed their application for this patent on April 17, 2000. The ’168 Patent was issued August 27, 2002. Merck…owner of the ’168 Patent. 19. Bayer Pharma is the exclusive licensee of the ’168 Patent for the sectors…infringes one or more claims of the ’ 168 Patent. 23. The ’168 Patent covers Bayer HealthCare’s Beyaz® tablets External link to document
2015-07-21 107 Asserted claim 4 of the U.S. Patent No. 6,441,168 (“the ‘168 patent”) is invalid under the on-sale…’850 PATENT. U.S. Patent No. 5,350,850 (“Vecchi”) anticipates claim 4 of the ‘168 patent. Some… the Vecchi patent alone, or in combination with the ’655 patent. IV. THE PATENT LACKS THE REQUIRED…BY THE ’850 PATENT. ...............................18 A. The Vecchi Patent Inherently…hold Claim 4 of the ‘168 patent invalid: (1) as anticipated by the Vecchi patent under Section 102(a); External link to document
2013-08-19 11 18. The patent-in-suit is U.S. Patent No. 6,441,168 (the “’168 Patent”) (attached hereto as…alleges infringement of one patent, U.S. Patent No. 6,441,168 (the “’168 patent”). Watson Labs admits that… of the ’168 patent. SECOND DEFENSE – INVALIDITY OF U.S. PATENT NO. 6,441,168 One or…invalidity and noninfringement of U.S. Patent No. 6,441,168 (“the ’168 patent”) and Watson Labs’ right to continue… ALLEGED INFRINGEMENT OF UNITED STATES PATENT NO. 6,441,168 21. Plaintiffs incorporate External link to document
2015-09-15 117 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,441,168 B1. (Attachments: #… 14 September 2015 1:13-cv-01272 830 Patent None District Court, D. Delaware External link to document
2013-09-09 15 invalidity and noninfringement of U.S. Patent No. 6,441,168 (“the ’168 patent”) and Watson Labs’ right to continue… DECLARATION OF NON-INFRINGEMENT OF U.S. PATENT NO. 6,441,168 22. Watson Labs repeats and realleges paragraphs…COUNTERCLAIM - DECLARATION OF INVALIDITY OF U.S. PATENT NO. 6,441,168 25. Watson Labs repeats and realleges paragraphs…the ’168 patent claims Beyaz®, and that patent infringement actions relating to the ’168 patent could reasonably…listing of the ’168 patent in the Orange Book, Bayer was representing to the world that patent infringement External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Moodys
Dow
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.